SCHEMBL4572102

SCHEMBL4572102

CSc1cc2c(O)cc(C(=O)O)c(-c3ccccc3)c2cc1SC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.45
GPR35 Q9HC97 1/20 0.44
POLB P06746 2/20 0.43
MCL1 Q07820 5/20 0.41
ACMSD Q8TDX5 3/20 0.41
HNF4A P41235 3/20 0.41
DHFR P00374 1/20 0.41
KDM4E B2RXH2 4/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
NSD2 O96028 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 3/20 0.37
ALDH1A1 P00352 3/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
HMGB1 P09429 1/20 0.37
CA4 P22748 1/20 0.37
CA6 P23280 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15452334 0.92 HNF4A (0.41) THRBGPR35POLBMCL1ACMSD
SCHEMBL15459720 0.89 MCL1 (0.49) THRBGPR35POLBMCL1ACMSD
SCHEMBL2018471 0.79 FABP3 (0.47) THRBGPR35POLBMCL1ACMSD
SCHEMBL1009517 0.79 THRB (0.65) THRBGPR35POLBMCL1ACMSD
SCHEMBL17736804 0.78 ALDH1A1 (0.54) THRBGPR35MCL1ACMSDHNF4A
SCHEMBL1010666 0.77 ACMSD (0.46) THRBMCL1ACMSDHNF4ADHFR
SCHEMBL9900350 0.76 THRB (0.61) THRBGPR35POLBMCL1ACMSD
SCHEMBL10137154 0.76 PTPN11 (0.44) THRBPTPN1
SCHEMBL4568718 0.75 GPR35 (0.33) GPR35POLBHTT
SCHEMBL15906524 0.75 FABP4 (0.39) THRBPOLBMCL1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8308996-B2 Chromene compound TOKUYAMA CORPORATION (JP) 2012-11-13 US disclosed
US-20120121934-A1 CHROMENE COMPOUND TOKUYAMA CORPORATION (JP) 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120121934-A1 CHROMENE COMPOUND TST, CNOT1, CNOT9 THRB 2364/4885GPR35 3753/4885POLB 3324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.